Peer review reports
From: Meropenem versus piperacillin-tazobactam for definitive treatment of bloodstream infections due to ceftriaxone non-susceptible Escherichia coli and Klebsiella spp (the MERINO trial): study protocol for a randomised controlled trial
Original Submission |
21 Sep 2014 |
Submitted |
Original manuscript
|
|
Author responded |
Author comments
|
|
Reviewed |
Reviewer Report
|
Resubmission - Version 2 |
|
Submitted |
Manuscript version 2
|
|
Author responded |
Author comments
|
Resubmission - Version 3 |
|
Submitted |
Manuscript version 3
|
Publishing |
22 Dec 2014 |
Editorially accepted |
|
27 Jan 2015 |
Article published |
10.1186/s13063-014-0541-9
|
Learn about peer review